DOK6 promoter methylation serves as a potential biomarker affecting prognosis in de novo acute myeloid leukemia

BACKGROUND: Downstream of tyrosine kinase 6 (DOK6), which is specifically expressed in the nervous system, was previously recognized as an adapter only in neurite outgrowth. Recent studies also demonstrated the potential role of DOK6 in solid tumors such as gastric cancer and breast cancer. However,...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Guo‐Kang, Tang, Li‐Juan, Zhou, Jing‐Dong, Xu, Zi‐Jun, Yang, Lan, Yuan, Qian, Ma, Ji‐Chun, Liu, Xing‐Hui, Lin, Jiang, Qian, Jun, Yao, Dong‐Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Cancer Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797566/
https://www.ncbi.nlm.nih.gov/pubmed/31486300
http://dx.doi.org/10.1002/cam4.2540

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797566/
https://www.ncbi.nlm.nih.gov/pubmed/31486300
http://dx.doi.org/10.1002/cam4.2540

Ejemplares similares